Curriculum Vitae
Total Page:16
File Type:pdf, Size:1020Kb
CURRICULUM VITAE PART I: General Information DATE PREPARED: January 15, 2019 Name: Paul M Ridker, MD, MPH, FACC, FAHA Eugene Braunwald Professor of Medicine Harvard Medical School Brigham and Women’s Hospital Office Addresses: Director, Center for Cardiovascular Disease Prevention Division of Preventive Medicine Brigham and Women’s Hospital 900 Commonwealth Avenue East, Boston, MA 02215 Tel: (617) 732-8790 Division of Cardiovascular Diseases Brigham and Women’s Hospital 75 Francis Street, Boston, MA 02115 Home Address: 1097 West Roxbury Parkway Chestnut Hill, MA 02467 E-mail: [email protected] Fax: (617) 734-1508 Place of Birth: St. Louis, Missouri Education: 1981 BS Brown University, Providence, RI 1986 MD Harvard Medical School, Boston, MA 1992 MPH Harvard School of Public Health, Boston, MA (Quantitative Methods and Epidemiology) Honorary Degrees: 2009 Doctorem Honoris Causa, University of Utrecht, The Netherlands 2009 Doctorem Honoris Causa, Universidad Abierta Interamericana, Argentina Postdoctoral Training: Internship and Residency 1986-89 Intern/Resident, Department of Medicine, Brigham and Women’s Hospital, Boston, MA 1989 Rotating Chief Medical Resident, Brockton-West Roxbury Veteran’s Administration Hospital, Boston, MA Clinical and Research Fellowships 1984-85 Sinclair-Kennedy Fellow, Harvard University, Boston, MA (Field work in Epidemiology in Zimbabwe, Zambia, Kenya) 1986-89 Clinical Fellow in Medicine, Harvard Medical School, Boston, MA 1989-92 Research Fellow in Medicine, Harvard Medical School, Boston, MA 1 of 151 Paul M Ridker, MD, MPH, FACC, FAHA 1989-91 Research/Clinical Fellow in Medicine (Cardiovascular Disease), Brigham and Women’s Hospital, Boston, MA Licensure and Certification: 1988 Board of Registration in Medicine, Commonwealth of Massachusetts 1989 Diplomate of the American Board of Internal Medicine 1991 Diplomate of the American Board of Internal Medicine, Subspecialty in Cardiovascular Disease Academic Appointments: 1992-93 Instructor in Medicine, Harvard Medical School, Boston, MA 1993-97 Assistant Professor of Medicine, Harvard Medical School, Boston, MA 1997-02 Associate Professor of Medicine, Harvard Medical School, Boston, MA 2002- Professor of Medicine, Harvard Medical School, Boston, MA 2003- Professor of Public Health, Harvard School of Public Health, Boston, MA 2003- Eugene Braunwald Professor of Medicine, Harvard Medical School, Boston, MA Hospital and Affiliated Institution Appointments: 1991-2 Associate Physician, Brigham and Women’s Hospital, Boston, MA 1992- Consulting Cardiologist, Southern Jamaica Plain Health Center, Boston, MA 2005- Senior Physician, Brigham and Women’s Hospital, Boston, MA 2005- Consulting Cardiologist, Dana-Farber Cancer Institute, Boston, MA 2007- Senior Cardiologist, Brigham and Women’s Hospital, Boston, MA Hospital and Health Care Organization Service Responsibilities: 1992- Attending Cardiologist, Clinical Service, Brigham and Women’s Hospital, Boston, MA 1992- Attending Cardiologist, Echocardiography Unit, Brigham and Women’s Hospital, Boston, MA 2011- Consulting Staff, Dana Farber Cancer Institute, Boston, MA Major Administrative Responsibilities: 1992-97 Director of Clinical Trials, Division of Preventive Medicine, Brigham and Women’s Hospital Boston, MA 1994-97 Co-Director, Cardiovascular Research, Division of Preventive Medicine, Brigham and Women’s Hospital, Boston, MA 1997-02 Co-Director, Blood Studies, Division of Preventive Medicine, Brigham and Women’s Hospital, Boston, MA 1997-03 Director, Cardiovascular Research, Division of Preventive Medicine, Brigham and Women’s Hospital, Boston, MA 1997-04 Chairman, PREVENT Trial, NHLBI 1999- Program Director, Cardiovascular Epidemiology Training Program, NHLBI/NRSA 1999-2001 Chairman, PRINCE Trial 2000-08 Co-Director, Leducq Center for Molecular and Genetic Epidemiology of Cardiovascular Disease, Brigham and Women’s Hospital 2000- Director, Center for Cardiovascular Disease Prevention, Brigham and Women’s Hospital 2003-10 Co-Director, Donald W. Reynolds Center for Cardiovascular Research, Harvard Medical School 2003-07 Chairman, ValMARC Trial 2004-10 Chairman, JUPITER Trial 2007- Director, Women’s Genome Health Study (WGHS) 2007-10 Chairman, LANCET Trial 2009-2015 Chairman, JUPITER Genome Wide Association Study 2 of 151 Paul M Ridker, MD, MPH, FACC, FAHA 2011- Chairman, CANTOS Trial 2011- Chairman, Cardiovascular Inflammation Reduction Trial (CIRT), NHLBI 2013-2018 Co-Chair, Executive Committee, SPIRE trials 2015- Co-Chair, PROMINENT Trial 2016- Executive Director, BWH Center for Community Wellness Major Committee Assignments: 1990-96 Steering Committee, International Studies of Infarct Survival (ISIS), Oxford, England 1992- Steering Committee, Women’s Health Study (WHS), Boston, MA 1993-95 Steering Committee, American Studies of Infarct Survival (ASIS), Boston, MA 1993-00 Steering Committee, Women’s Antioxidant Cardiovascular Trial (WACS), Boston, MA 1994-04 Council on Thrombosis, American Heart Association 1994- Council on Epidemiology and Prevention, American Heart Association 1995-99 Endpoints Committee, ACHIEVE Trial, Philadelphia, PA 1996-99 Cardiology Advisory Board, Owen Health Care 1997-00 Board of Directors, Central Boston Division, American Heart Association 1997-99 Medical Advisory Council, Alcoholic Beverage Medical Research Foundation 1997-04 Chairman, Steering Committee, PREVENT Trial, Boston, MA 1998-03 Ad Hoc Reviewer, Clinical Trials Review Committee, National Heart, Lung, and Blood Institute 1998-02 American Heart Association, Committee on Cardiovascular Prevention 1999-01 Advisory Committee, International Society on Thrombosis and Haemostasis 1999-01 International Advisory Committee, Fibrinogen & Inflammation, Paris, France 1999-02 American Heart Association, Liaison for Population Biology 1999-2001 Chairman, Steering Committee, PRINCE trial, Boston, MA 1999-01 Reviewer, Special Emphasis Panel on Inflammation, National Heart, Lung, and Blood Institute, Bethesda, MD 1999-04 American Heart Association, Cardiovascular Epidemiology, Council 2000-04 Genetics Advisory Panel, Harvard Medical School 2000-04 Steering Committee, High Throughput Genotyping Center, Brigham and Women’s Hospital 2000-04 Operations Committee, Tissue and Blood Repository, Brigham and Women’s Hospital 2000-05 Advisory Board to the Office of Corporate Sponsored Research and Licensing, Partners HealthCare 2001-05 Associate Editor, Seminars in Vascular Medicine 2001-06 Joint Steering Committee, Partners HealthCare/ Millennium Pharmaceuticals Collaborative 2001-06 Reviewer, Medical Council, Doris Duke Charitable Foundation 2001-04 Advisor, National Health Lung and Blood Institute, Specialized Centers of Clinically Oriented Research (SCCOR) 2002-07 Leadership Committee, Council on Epidemiology and Prevention, American Heart Association 2003-07 Data and Safety Monitoring Board, HOST Trial, US Veterans Administration 2003-11 Chairman and Principal Investigator, JUPITER Trial 2003-09 Scientific Board, Stanley J Sarnoff Endowment for Cardiovascular Science 2003-07 Chairman, Valsartan-Managing Blood Pressure Aggressively and Evaluating Reduction in CRP Trial (Val-MARC) 2006-10 Chairman, Steering Committee, LANCET Study 2006-2010 Executive Advisory Board, Harvard Institute for Global Health (HIGH) 2006-2013 Pharmacogenetics and Risk of Cardiovascular Disease Network (PARC), NHLBI 2006-2017 Board of External Advisors (BEE), National Heart Lung and Blood Institute 2008- Chairman, Steering Committee, JUPITER GWAS 2011-2015 Reviewer, NHLBI Extramural Loan Repayment Program (LRP) 3 of 151 Paul M Ridker, MD, MPH, FACC, FAHA 2011- Chairman, Steering Committee, CANTOS Study 2011-2016 Chairman, Genetics Informatics Trial (GIFT) Data Safety Monitoring Board (DSMB), NHLBI 2011- Chairman, Steering Committee, Cardiovascular Inflammation Reduction Trial (CIRT), NHLBI 2012-2016 Data and Safetly Monitoring Board, ACELERATE 2012-2015 Co-Chair, NHLBI HIV/AIDS CVD Working Group / Workshop, Bethesda, MD 2012-2016 NHLBI Science Moving towards Resaerch Tranlsation and Therapy (SMARTT) Review Panel, Bethesda, MD 2013-2014 NHLBI Special Emphasis Panel, NHLBI Institutional Training SEP, Bethesda, MD 2013 Joint Review Panel, Medical Research Council (MRC), British Heart Foundation (BHF), United Kingdom Cancer Research, Oxford England 2013 Committee on Publications (New England Journal of Medicine), Massachusetts Medical Society, Boston, MA 2013- Executive Committee, STRENGTH 2013-2018 Co-Chair, Executive Committee, Studies of PCSK9 Inhibition and the Reduction of vascular Events (SPIRE) 2014- Executive Committee, AEGIS 2015-2017 Co-Chair, NHLBAC Working Group on Clinical Trials 2015-2017 Co-Chair, NHLBI Working Group on HIV and Cardiovascular Disease 2017 USFDA Cardiorenal Advisory Panel 2017 Member, Peter Munk Scientific Advisory Board, UHN Toronto, Canada 2018 British Heart Foundation Review Panel, University of Oxford, United Kingdom Professional Societies: 1985-91 Peabody Society, Harvard Medical School, Boston, MA 1992- American College of Physicians 1993- American College of Cardiology (FACC) 1993- American Heart Association 1994-04 International Society of Thrombosis and Hemostasis 1994-04 North American Antithrombotic Consortium 1995- American Federation of Clinical Research 1999- American Society for Clinical Investigation (ASCI) 1999-02 American Association for the Advancement of Science 2000-05 New York Academy of Sciences 2000-05 American Epidemiological Society (AES) 2002- American Association of Physicians (AAP) 2004-09 National